Peptidyl-arginine deiminase: An additional marker of rheumatoid arthritis

Clinical Laboratory

Volumn 57, Issue 11-12, 2011, Pages 1021-1025

  Basu, Pranab S ^a   Majhi, Ramdhan ^b   Ghosal, Samit ^c   Batabyal, Sandip K ^c  

^a HERITAGE INSTITUTE OF TECHNOLOGY   (India)

^b INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^c Nightingale Hospital   (India)

Author keywords

CCP; Peptidyl arginine deiminase; RF; Rheumatoid arthritis

Indexed keywords

BENZOYLARGININE ETHYL ESTER; C REACTIVE PROTEIN; CITRULLINE; PROTEIN ARGININE DEIMINASE;

ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; JOINT SWELLING; LEUKOCYTE COUNT; METABOLISM; MORNING STIFFNESS; PAIN ASSESSMENT; RHEUMATOID ARTHRITIS; SPECTROPHOTOMETRY; THROMBOCYTE COUNT; TURBIDIMETRY; VISUAL ANALOG SCALE;

ADULT; AGED; ANTIBODY SPECIFICITY; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CITRULLINE; FEMALE; HUMANS; HYDROLASES; MALE; MIDDLE AGED; MUSCULOSKELETAL DISEASES; PREDICTIVE VALUE OF TESTS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 83455233902     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Gordon L. Round 4: Citrullinated proteins, peptidylarginine deiminase (PAD), and Rheumatoid Arthritis. Johns Hopkins Arthritis Center Newsletter. 2008 (May 1).
2. Schelleken GA, Vesser H, de Jong BA, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000,43:155-63.
3. Bizzaro N. Diagnostic accuracy of the anti-citrulline antibody for rheumatoid arthritis. Clin Chem 2001,47:1089-93. (Pubitemid 32493596)
4. Vossenaar ER, van Venrooij WJ. Anti-CCP antibodies, a highly specific marker for (early) rheumatoid arthritis. Clin Applied Immunol Rev 2004,4:239-62. (Pubitemid 38495780)
5. Corconnier C, Diagnostic value of anti-RA33 antibody, antikeratin antibody, anti-perinuclear factor and anti-nuclear antibody in early rheumatoid arthritis: Comparison with rheumatoid factor. Brit J Rheumatol 1996,35:620-4.
6. van Venrooij WJ. Citrullination: A small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res 2000,2:249-51. (Pubitemid 32223741)
7. Rantapaa-Dahlqvist S, de Jong W, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003,48:2741-9. (Pubitemid 37280601)
8. Nielen MM, van Schaardenburg D, Reesink H, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors. Arthritis Rheum 2004,50:380-6. (Pubitemid 38198821)
9. Arnett FC, Edworthy SM, Bloch DA. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum1988,31:315-24. (Pubitemid 18091653)
10. Watanabe K, Akiyama K, Hikichi K, et al. Combined biochemical and immunochemical comparison of peptidylarginine deiminase (E.C. 3.5.3.15) present in various tissues. Biochim Biophys Acta 1988,966:375-83.
11. Boyde TRC, Rahmatullah M. Optimization of conditions for the colorimetric determination of citrulline, using diacetyl monoxime Analytical Biochem 1980,107:424-31. (Pubitemid 11220248)
12. Schellekens GA, de Jong B, van den Hoogen F. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis specific autoantibodies. J Clin Invest 1998,101:273-81. (Pubitemid 28058927)